Dr. Preda’s research bridges basic neuroscience and clinical application by developing imaging-based biomarkers for symptom dimensions and treatment response. His studies link specific connectivity patterns to major psychiatric symptoms clusters, including positive and negative symptoms, formal thought disorder, and cognitive deficits. Recent work includes investigations of brain age acceleration, genetic risk factors, and pharmacological interventions like oxytocin and ketamine as models for understanding therapeutic mechanisms.

Dr. Preda’s research focus on methodological innovation (harmonization techniques, novel connectivity metrics), clinical translation, and its emphasis on reproducibility through large consortia and sophisticated analytical approaches positions it at the forefront of precision psychiatry initiatives.